C0378466_Pharmacokynetic_C0068475

Property	Value
?:effect	<https://research.tib.eu/covid-19/entity/C0025519>
?:hasPrimarySource	<https://research.tib.eu/covid-19/SourceName/UMLS>
?:impact	decrease
?:interaction	The metabolism of Nebivolol can be decreased when combined with Zafirlukast.
?:objectDrug	<https://research.tib.eu/covid-19/entity/C0068475>
?:object_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB04861>
?:precipitantDrug	<https://research.tib.eu/covid-19/entity/C0378466>
?:precipitant_hasDrugBankID	<https://research.tib.eu/covid-19/entity/DB00549>
?:type	<https://research.tib.eu/covid-19/vocab/DrugDrugInteraction> <https://research.tib.eu/covid-19/vocab/PharmacokyneticDrugDrugInteraction>

Metadata

Anon_0

expand all